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Background: Preterm birth is the main cause of morbidity and mortality during the perinatal period. Classical risk
factors are held responsible for only 1/3 of preterm births and no current intervention has produced an appreciable
reduction of this event. It is necessary to explore new hypotheses and mechanisms of causality by using an
integrated approach, collaboration among research groups and less fragmented theoretical-methodological
approaches in order to detect new risk factors and to formulate more effective intervention strategies.
Methods: The study will be conducted on a convenience cohort of Brazilian pregnant women recruited at public
and private prenatal health services. A total of 1500 pregnant women in São Luís, and 1500 in Ribeirão Preto, will
be invited for an interview and for the collection of biological specimens from the 22nd to the 25th week of
gestational age (GA). At the time of delivery they will be reinterviewed. GA will be determined using an algorithm
based on two criteria: date of last menstruation (DLM) and obstetric ultrasound (OUS) performed at less than 20
weeks of GA. Illicit drug consumption during pregnancy will be determined using a self-applied questionnaire and
the following instruments will be used: perceived stress scale, Beck anxiety scale, screening for depression of the
Center of Epidemiological Studies (CES-D), experiences of racial discrimination, social network and social support
scale of the Medical Outcomes Study and violence (Abuse Assessment Screening and violence questionnaire of the
WHO). Bacterial vaginosis, urinary tract infection and periodontal disease will also be identified. Neuroendocrine,
immunoinflammatory and medical intervention hypotheses will be tested. The occurrence of elective cesarean
section in the absence of labor will be used as a marker of medical intervention.
Conclusion: Psychosocial, genetic and infectious mechanisms will be selected, since there are indications that they
influence preterm birth (PTB). The studies will be conducted in two Brazilian cities with discrepant socioeconomic
conditions. The expectation is to identify risk factors for PTB having a greater predictive power than classically
studied factors. The final objective is to propose more effective interventions for the reduction of PTB, which, after
being tested, might subsidize health policies.
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Preterm birth (PTB) is currently one of the most important
perinatal problems because of its association with signifi-
cant morbidity and mortality at the beginning of life [1-3].
Its prevalence is high and is increasing in developed coun-
tries [4,5] and in some Brazilian cities [6,7].
The etiology of PTB is not well known [8]. Gestational
risk factors such as infections, multiple births, hypertension,
smoking habit and the use of illicit drugs, exhausting work,
low body mass index, insufficient weight gain, low maternal
schooling, black race, and a history of preterm births have
been demonstrated to be responsible for only one third of
preterm deliveries [9,10]. These conditions seem to be
markers of more distal causes that need to be identified [11].
Thus, other etiologies should be better studied.
There is growing evidence that maternal prenatal
stress is a potent risk factor for adverse birth outcomes,
an effect that may be mediated by biological and behav-
ioral factors [12,13]. Ruiz et al. [14] reported that dis-
equilibrium of maternal hormonal homeostasis caused
by stress might contribute to a significant proportion of
preterm births.
The racial question has also received attention regard-
ing the etiology of PTB, with black women presenting a
two to three times higher chance of delivering preterm
than white women [15]. Several studies have demon-
strated an association between the experience of racial
discrimination and an increased risk of PTB and low
birth weight [16-18].
Another situation that is being related to worse neo-
natal outcomes is violence during pregnancy. A study
conducted in India detected a 2.59 times higher risk of
perinatal and neonatal mortality for the babies of women
who are victims of domestic violence [19]. Nogrum et al.
[20] demonstrated that domestic violence was associated
with prenatal and postnatal depression, complications of
pregnancy, PTB and low birth weight. Despite the mag-
nitude of the problem, few studies have been devoted to
the investigation of the association between domestic
and family violence against women and PTB.
Among the known causes of PTB are maternal infec-
tions. There is a consensus that infections trigger inflam-
matory responses in the mother and in the fetal tissues
that may lead to the production of prostaglandins, in-
creased myometral contractility, rupture of the fetal
membranes, and consequent PTB [21-23]. However, no
study has evaluated simultaneously the three infections
most often implicated: bacterial vaginosis, periodontal
disease, and urinary tract infection. Also, no studies have
determined whether these three types of infection share
the same profile of cytokine release, i.e., whether these
cytokines act according to a determined physiopatholog-
ical mechanism or whether there is a specific inflamma-
tory response to each type of infection.One of the unclear points in the epidemiology of PTB is
the fact that some women experience an infectious stimu-
lus, which, however, is unable to activate the inflammatory
cascade and trigger PTB. It has been proposed that the in-
flammatory cascade may be activated only in genetically
predisposed women [23]. Macones et al. [24] detected evi-
dence of an association between genetic susceptibility in pa-
tients carrying polymorphism of the TNF-α gene (allele 2)
and affected by symptomatic bacterial vaginosis with a
higher risk of spontaneous premature delivery. However,
the same was not observed in women with periodontal
disease [25].
High rates of medical intervention in pregnancy also
seem to contribute to an increased PTB rate. One in three
of the more than 4 million births per year is by cesarean
section and adjusted risk measurements may vary accord-
ing to race and ethnicity [26]. Cesarean section rate has in-
creased by more than 50% from 20.7% in 1996 to 32.8% in
2011 [27]. A parcel of medically induced deliveries appears
to be indicated incorrectly, provoking iatrogenic prematur-
ity [6,7]; however, it is not known how much of the increase
in PTB can be attributed to abusive intervention.
Although studies on aggravating factors are important,
it is also necessary to better understand the protective fac-
tors. Social ties seem to influence the maintenance of
health, favoring adaptive conducts in situations of stress
[28,29]. Studies have demonstrated that a lower social
support during the prenatal period is associated with low
birth weight and PTB [28,30].
In the current protocol, the cited risk factors will be
evaluated as components of three causality chains: the
neuroendocrine, immunoinflammatory and medical inter-
vention hypotheses.
The first hypothesis to be tested is the neuroendocrine
one (Figure 1). Several psychosocial factors will be investi-
gated: experience of racial discrimination, lack of social
support, domestic violence against women, stress, and de-
pression. The hypothesis is that all of these factors may act
through a common physiological pathway, activating the
hypothalamus-pituitary-adrenal axis and consequently the
cascade of neuroendocrine events that promote stress,
leading to the release of oxytocin and prostaglandin and
inducing preterm delivery [31]. Another question to be
investigated is whether genetically susceptible individuals
with polymorphism in the region regulating corticotropin-
releasing hormone (CRH) would be particularly predisposed
to the occurrence of preterm delivery in the presence of
stressful situations [11,32].
The second hypothesis is the immunoinflammatorry one
(Figure 2). Three infections will be studied as possible stim-
uli capable of triggering the immunoinflammatory response
that might lead to preterm delivery, i.e., bacterial vaginosis
[33], periodontal disease [22,34] and urinary tract infections
[35]. Based on this hypothesis, the stimuli generated by
Figure 1 Schematic diagram of the neuroendocrine hypothesis.
da Silva et al. Reproductive Health 2014, 11:79 Page 3 of 9
http://www.reproductive-health-journal.com/content/11/1/79these infections could lead to the release of proinflammatory
cytokines (especially TNF-α and interleukins IL-1β, IL-6 and
Il-10 in maternal blood), inducing an intra-amniotic inflam-
matory response that would trigger premature contractions,
cervical dilation and rupture of fetal membranes, leading to
preterm delivery [24,25].
The third hypothesis to be tested is medical intervention.
According to this hypothesis, there would be a reduction of
stillbirths associated with an increase in low birth weight
and PTB [6,7,36]. Women who undergo medical interven-
tions would present higher PTB rates than all other preg-
nant women, adjusted for the remaining confounding
factors [6,5].
Thus, the objective of the present protocol is to investigate
new factors in the etiology of PTB using an integrated and
collaborative approach in two Brazilian cities in a cohort
study started during the prenatal period. The following as-
pects will be evaluated as specific objectives considering the
new hypotheses (neuroendocrine and immunoinflamma-
tory): the association of domestic and family violence with
PTB; to what extent the experience of racial discrimination
promotes changes in the maternal organism that would trig-
ger PTB; the influence of maternal stress during pregnancy
on the birth of preterm babies; the association between ma-
ternal infections (bacterial vaginosis and urinary infection)
and the triggering of PTB; the association of periodontalFigure 2 Schematic diagram of the immunoinflammatory hypothesis.infection, presence of caries lesions and endodontic infec-
tions in the oral cavity of pregnant women with the occur-
rence of PTB; whether genetic susceptibility linked to
polymorphism in the coding of TNF-α and CRH would
confer a higher risk of preterm delivery.Methods
Time period of the study
The protocol “Etiological factors of PTB and consequences
of perinatal factors on the health of children: birth cohorts
in two Brazilian cities” , denoted BRISA (Brazilian Ribeirão
Preto and São Luís Birth Cohort Studies), conducted by the
Federal University of Maranhão (UFMA) and the Faculty of
Medicine of Ribeirão Preto, University of São Paulo (FMRP/
USP), will be carried out in two Brazilian cities with con-
trasting socioeconomic indicators: São Luís and Ribeirão
Preto.
The city of Ribeirão Preto (RP) is located in the Northeast-
ern region of the State of São Paulo, a rich and industrialized
region with a Human Development Index (HDI) of 0.800 in
2010, ranking in 40th position in Brazil [37]. Its population
was 604,682 inhabitants in 2010 [38]. It is one of the most
developed cities in the country, with 99% of all residences
receiving piped water and equipped with a sewage system.
Its main economic activity is sugar cane agro-industry, in
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gional university center [39].
The city of São Luís (SL), the capital of the state of
Maranhão, is located in Northeastern Brazil. Its HDI was
0.768 in 2010, with the city ranking in 249th position in
Brazil. The city is located in one of the poorest regions in
the country and its population was 1,014,837 inhabitants
[38] in 2010. Its economic activity is based on aluminum
metallurgy, ore export from the Carajás mountains and
state production of soy, in addition to commerce and ser-
vices [40].Protocol design and population
The reference population will consist of pregnant women
receiving prenatal care at health services of the public and
private networks. The goal is to obtain a convenience sam-
ple of approximately 1500 women in each city since it is not
possible to obtain a random sample representative of preg-
nant women of the population because of the lack of regis-
tries of pregnant women or women receiving prenatal care.
A total of 1500 women will be invited for interview in
each city during the prenatal period, from the 22nd to
the 25th week of gestational age (GA). At the time of de-
livery, they will be reinterviewed after the birth of their
babies. On that occasion, the hospitals of the two cities
will be monitored daily for the identification of women
belonging to the cohort.
Preterm birth is considered to be a birth occurring
before 37 weeks of gestational age (GA). GA will be deter-
mined using an algorithm based on two criteria: date of
last menstruation (DLM) and obstetric ultrasound (OUS)
performed at less than 20 weeks of GA. When GA mea-
sured on the basis of DLM is 10 days more or less than
the value estimated by OUS, the GA value calculated from
DLM will be used or, otherwise, the GA estimated by
OUS will be used [41].
This is a protocol for a prospective nested case–control
study. The nested case–control design increases the effi-
ciency of the study since there is no need to analyze bio-
logical specimens for all controls. All preterm babies
identified in the cohort will be cases and two controls per
case will be chosen at random from the rest of the cohort.
This strategy reduces costs, practically maintaining the same
statistical power equivalent to the analysis of the entire
cohort. Only psychosocial variables and other variables ob-
tained with a questionnaire during the interview (which re-
quire a prospective collection in order to reduce recall bias)
will be measured for the entire cohort.Inclusion criteria
The inclusion criterion will be OUS performed before the
20th week of pregnancy since it is a more reliable estimate
of GA. The exclusion criterion will be multiple pregnancy,which has been pointed out as one of the main determi-
nants of PTB, even in the absence of complications.
Data collection and recruitment strategies
The women will be contacted in ultrasound clinics and pre-
natal care offices and invited to come to the Clinical Re-
search Center of the University Hospital, Federal University
of Maranhão, São Luís, or to the Clinical Research Unit of
the University of São Paulo, Faculty of Medicine of Ribeirão
Preto, to participate in the study. The project will be pre-
sented and disseminated in the media, and a telephone
number will be provided for the interested mothers to con-
tact the research team and schedule an interview according
to the procedure used for a previous cohort [39].
All pregnant women who fulfill the inclusion criteria
and who are interested in the project will be registered.
The registration form contains identification data (name,
address, personal telephone and telephones of family
members), place were prenatal care visits were per-
formed, and gestational age calculated by ultrasound.
After filling out the registration form, the subjects will re-
ceive a card with the date and time to arrive at the site of
data collection, where the interviews will be held and the
exams will be performed. At the site of data collection, the
subjects will give written informed consent to participate in
the study, respond to a general prenatal questionnaire and
a self-applied questionnaire and will be submitted to an-
thropometry (weight, height), blood pressure measurement,
collection of biological specimens (blood, urine and vaginal
secretion), dental and ultrasound examination.
Instruments and variables
Two standardized questionnaires will be used for data
collection: one of them applied by the interviewers and
the other self-applied.
The ABUSE–Assessment Screen questionnaire developed
by the Nursing Research Consortium on Violence and
Abuse [42] will be used as reference for the screening of
physical and sexual abuse against pregnant women. A short
version of the violence questionnaire of the World Health
Organization will also be used. For psychological (emo-
tional) violence, women will be asked whether since you
were pregnant has someone: V1) insulted you or made you
feel bad about yourself?; V2) belittled or humiliated you in
front of others?; V3) intimidated or scared you on purpose?;
V4) threatened to hurt you or somebody you care about?
[19]. Regarding physical violence, the pregnant women will
respond to the following questions: since you were preg-
nant has someone V5) slapped you or thrown something at
you that could hurt you?; V6) pushed or shoved you, hit
you with a fist or something else that could hurt?; V8)
kicked, dragged or beaten you up?; V9) choked or burnt
you on purpose?; V10) threatened you with, or actually
used a gun, knife or other weapon against you? [19]. The
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were pregnant V11) has someone ever physically forced
you to have sexual intercourse against your will?; V12) have
you ever had sexual intercourse because you were afraid of
what your partner might do?; V13) has someone ever
forced you to do something sexual you found degrading or
humiliating? [19]. Violence will be identified when the preg-
nant woman respond “once”, “seldom” or “often” to one of
the above questions.
Two instruments will be used to assess maternal stress:
Perceived Stress Scale and reports of stressful life events.
Stress will be considered to be present when >75th percent-
ile. The Center for Epidemiological Studies depression scale
(CES-D) will be used to assess maternal depression. Severe
depressive symptoms will be considered to be present when
the score is ≥22. Intense anxiety will be identified when the
pregnnat woman scores ≥30 points on the Beck anxiety
Scale.
Experiences of racial discrimination will be evaluated
by applying a questionnaire elaborated by Krieger [43]
and used in the CARDIA [44] and the PRÓ-SAÚDE
study in Brazil [45].
Social support and social support network will be evalu-
ated using the social support scale of the Medical Outcomes
Study (MOS). The scale was translated and adapted to
Portuguese and later validated and used in the Pró-Saúde
study on a cohort of employees of a Brazilian public Univer-
sity [46,45]. Greater social support will be considered to be
present when the replies are above the 75th percentile.
The questionnaire, to be applied by the interviewer,
contains questions about socioceconomic and demo-
graphic data (schooling, occupation, family income, mari-
tal status, religion, number of household members, and
CCEB (Brazilian economic classification criterion in the
Portuguese acronym), life habits (maternal use of alcohol,
smoking habit and consumption of coffee, tea and choc-
olate), sexual and reproductive data (liveborns, stillborns
and abortions), diseases and use of medications during
pregnancy, characteristics of the current pregnancy and of
prenatal care (receiving prenatal care; beginning of
prenatal care; number of visits; place of prenatal care;
presence of hypertension during pregnancy; chronic
hypertension; chronic hypertension of the father and
hypertension among family members; DLM; sexual and
reproductive data (number of sex partners; sexually trans-
missible disease of the partner; use of contraceptive
methods; type of contraceptive used); oral health data
(oral health before pregnancy; gingival problems during
pregnancy; changes in dental condition and indication of
treatment by a dentist), use of fat-rich foods by means of
the Block Score. The short version of the International
Physical Activity Questionnaire (IPAQ) will be used to de-
termine the physical activity of the pregnant women, clas-
sified as vigorous or heavy, moderate and light.Dental examination
The subjects will be submitted to clinical dental examin-
ation for the diagnosis of periodontal disease and caries.
To this end, six examiners will be trained regarding the
different research indexes (intraexaminer and interexa-
miner Kappa ≥0.80). All oral examinations will be per-
formed in a dental office under artificial light according
to WHO recommendations [47]. A no. 5 mouth mirror
and a periodontal probe graduated in millimeters (North
Carolina n°15/OMS #11.5, Hu-Friedy© 2013, Mfg. Co.
LLC) will be used for the measurements.
Periodontal changes will be determined using the bleed-
ing on probing (BOP) index [48], visible plaque index (VPI)
[49], calculus index (CI) [50], probing pocket depth (PPD),
and clinical attachment level (CAL) [51]. Because of the
lack of a universally accepted criterion for the classification
of periodontal disease [52], two different classifications will
be used: a) the classification of the American Academy of
Periodontology [53,54] which considers three levels of se-
verity of periodontal disease on the basis of clinical loss of
attachment (CAL) as follows: slight =1–2 mm CAL; mod-
erate =3 to 4 mm CAL; and severe =5 mm CAL; and b) an-
other more specific criterion whereby a person is
considered to have periodontitis when he/she presents at
least two interproximal sites in different teeth with clinical
attachment level ≥4 mm and/or at least two interproximal
sites in different teeth, with probing depth ≥5 mm [55].
Dental caries will be determined only after dental prophy-
laxis and will be diagnosed on the basis of the DMFT index
(number of decayed, missing and filled teeth) [56]. The
presence of residual roots, fistulas or teeth with exposed
crown chambers that might reflect endodontic infection
will also be evaluated and diagnosed by clinical examin-
ation. The PUFA index (exposed Pulp, Ulceration of the
oral mucosa by dislocated root fragments, Fistula and Ab-
scesses) will be used to identify the presence of endodontic
infection [57].
Laboratory exams
Urine will be collected for the investigation of asymptomatic
bacteriuria and urinary tract infection [58]. Asymptomatic
bacteriuria will be identified by the presence of ≥100,000
colonies/ml in urine culture.
Vaginal secretion will be collected for the diagnosis of bac-
terial vaginosis and the diagnostic criterion is a Nugent
score of 7 or more or the presence of clue cells [59-61].
The vaginal content will be collected and stored in
Eppendorf tubes at −80°C for later processing and quantita-
tion of metalloproteinases (MPPs) 2 and 9 and identifica-
tion of Clamydia by PCR. After homogenization of the
vaginal content, MMPs 2 and 9 will be determined by
ELISA (Quantikine Elisa Kit – R&D Systems Human MPP-
2 and ELISA Kit - Invitrogen– Human MMP-9). Clamydia
will be identified by PCR.
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as their antimicrobial susceptibilities, will be investigated
with the commercially available Mycoplasma IST 2 Kit
(bioMérieux, Marcy-l’Étoile, France) as indicated by the
manufacturer. Briefly, the endocervical cotton swab in-
cluded in the kit will be inoculated in R1 transport medium,
inhibiting most of the Gram-negative and Gram-positive
bacteria. The inoculated R1 medium will be vortexed rap-
idly and 3 mL will be added to the growth R2 medium,
which contains 1 mL of lyophilized urea/arginine broth.
After reconstitution and shaking, 55 μL will be dispensed
into each of the 22 test wells on the strip. Two drops of
mineral oil will be added to each well. The remainder of
the R2 medium and the inoculated strip will then be
incubated at 37°C and observed for color changes at 24
and 48 h. The antimicrobial susceptibility testing will
include tetracycline, doxycycline, erythromycin, azithro-
mycin, clarithromycin, josamycin, ofloxacin, ciprofloxacin
and pristinamycin. The development or absence of red
colour on the relevant part of the strip provides an index
of resistance or susceptibility to each antimicrobial agent,
respectively, according to the guidelines of the CLSI.
Thirty-two ml blood will be collected by peripheral
venipuncture into four tubes containing EDTA (purple),
four yellow tubes containing a gel activator, and one blue
tube and sent to the laboratory. Blood will be centri-
fuged for the separation of serum, plasma and whole
blood. The material obtained will be placed in Eppendorf
tubes labeled and stored frozen at −80°C. The whole
blood fraction will be used for DNA extraction for the
study of TNF-α and CRH gene polymorphism. The
serum fraction will be used to quantitate the levels of 42
pro- and anti-inflammatory cytokines with a high sensi-
tivity kit (Milliplex Map Human Cytokine/Chemokine.
Cat HCYTOMAG-60K-PX41 Millipore Corporation,
Billerica, MA, USA) and TGF-β will be determined by
ELISA (Elisa Human TGF Beta-1 R&D System). Plasma
will be used to quantitate MPPs 2 and 9 by ELISA
(Quantikine Elisa Kit – R&D Systems Human MMP-2
and ELISA Kit - Invitrogen– Human MMP-9).
Detection of TNF-α and CRH gene polymorphism
For the analysis of TNF-α and CRH gene polymorphism,
genomic DNA will be extracted from peripheral blood pre-
natally obtained from the pregnant women according to
the adapted technique of Sambrook, Fritsch and Maniatis
[62]. The alleles at position – 307 of the promoter region of
gene TNF-α will be detected by PCR-RFLP. A 107 bp
fragment will be amplified using the primers 5`AGGCAA-
TAGGTTTTGAGGGCCAT-3` and 5`TCCTCCCTGCTC
CGATTCCG-3` (GDB:196368). The total volume of the
amplification reaction will be 25 μL, containing 1 μL gen-
omic DNA (25 ng), 1X buffer (Invitrogen), 0.25 pmol of
each primer, 0.05 μM dNTP, 1.5 mM MgCl2 and 1 U TaqDNA polymerase. PCR will be started with 5 minutes of de-
naturation at 95°C, followed by 35 cycles of 20 seconds at
95°C, 20 seconds at 59°C and 20 seconds at 72°C. PCR will
be finalized by a final extension for 10 minutes at 72°C.
Digestion of the 307G allele by the enzyme NcoI pro-
duces fragments of 87 and 20 pb, while the 307A allele is
not cleaved by the enzyme, generating a fragment of 107 bp
[63,24]. The amplified fragments will be digested for 3
hours at 37°C, submitted to 3% agarose gel electrophoresis
and visualized by ethidium bromide staining.
Polymorphism of the 5` flanking region of the CRH gene
will be determined by digestion with the enzyme XmnI,
which permits the detection of the variant (T255G) [64].Obstetric ultrasonography
On the day of collection of clinical and laboratory data, all
pregnant women will be submitted to morphological OUS
with analysis of fetal biometry and morphology and uterine
artery Doppler using a transducer by the abdominal route.
They will also be evaluated in terms of the length and bio-
physical characteristics of the uterine cervix using a trans-
ducer by the vaginal route.Statistical analyses
The primary outcome will be preterm birth (<37 weeks of
GA). Data will be analyzed by multiple binary logistic re-
gression with estimate of the odds ratio. Modeling with
structural equations will also be used to reduce measument
errors. This form of hierarchical modeling has been used to
interpret complex relationships between variables and has
advantages over classical regression analysis. It is more ap-
propriate by permitting an estimate of direct and indirect
effects (mediation effect) and a better control of confound-
ing factors by also adjusting for common causes. When the
variables are measured in an imperfect manner (as is the
case for most psychosocial variables such as stress, experi-
ences of racial discrimination and social support), latent
variables are created. These latente variables, which are not
directly observed, are derived from the structure of covari-
ance between two or more indicator variables (observed
variables are used to estimate the latent variable). The latent
variables are free of measurement errors. With the use of
this modeling it is possible to construct a network of struc-
tural relations arranged in a hierarchical manner into distal,
intermediate and proximal causes based on the hypothesis
derived from theory, and to test the adjustment of the
model as a whole. Modeling with structural equations con-
sists of a series of multiple regression equations, with all
equations being adjusted simultaneously. Various scales
used in the study will be validated by confirmatory factor
analysis before being used in the complete structural equa-
tion model [65].
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The reported prevalences of the explanatory variables range
from 10 to 50%. Thus, considering a 12% PTB rate, the ini-
tial plan is to recruit 3000 women (1500 in ecah city), a
number that would lead to a total of 360 cases. The nested
case control will thus be based on 360 cases and 720 con-
trols (two controls per case), with a 5% probability of type I
error and an 80% power to detect an odds ratio of 1.7 asso-
ciated with a prevalence as low as 12% of the explanatory
variables, even in the presence of moderate confounding
(OR of 1.8 for confounding).
Data processing
Data will be entered in duplicate using the Microsoft
Office Access 2007 software. The two sets of entries will
be compared and errors corrected. Inconsistencies will
be corrected.
Ethical considerations
The protocol satisfies the criteria of Resolution 196/96 of
the National Health Council and its complementary norms
and was approved in all of its phases by the Research Ethics
Committe of the University Hospital, FMRP/USP (Protocol
N°. 4116/2008) and of the University Hospital of the Fed-
eral University of Maranhão (Protocol N°. 4771/2008-30).
The mothers who agree to participate in the study will give
written informed consent and will be informed that they
could drop out at any time during the study with no harm
to themselves or their families.
Discussion
The proposed protocol focuses on the question of PTB,
whose rates have continued to be increasing in both devel-
oped and developing countries for more than a decade
[1,2]. No current intervention has had an appreciable
impact on the reduction of this event [66-70]. Thus, there
is a need to explore new hypotheses and mechanisms
of causality using an integrated approach, collaboration
among research groups, and less fragmented theoretical-
methodological approaches.
New risk factors for PTB, such as experience of racial
discrimination, stress during pregnancy, domestic vio-
lence against women, lack of social support, maternal in-
fections (bacterial vaginosis, infections of the oral cavity
and urinary tract infections) genetic susceptibility (poly-
morphisms in the coding of TNF-α and CRH), and med-
ical interventions will be evaluated under the present
protocol [12,13,17,20,25,33].
The classical risk factors for PTB only explain part of
its occurrence [8]. New hypotheses need to be tested so
that effective interventions are proposed. Psychosocial,
genetic and infectious mechanisms were selected for in-
vestigation since there are indications that they play an
expressive role in the determination of PTB.The proposals of the study at the two locations will be ar-
ticulated with each other, both in terms of the research
teams of the two centers and the use of the same instru-
ments. The study will be conducted in two Brazilian cities
with discrepant socioeconomic realities.
The expectation is to identify risk factors for PTB having
a greater predictive power than classically studied factors.
After the identification of these factors, the intention is to
design more specific intervention strategies to be tested. In
the current literature, risk factors have been tested individu-
ally, with few protocols having been proposed like the
present one, in which the factors are investigated using an
integrated multidisciplinary approach and a hierarchical
modeling based on data from samples of two cities with
contrasting socioeconomic profiles. The final objective is to
propose more effective strategies for the reduction of PTB,
which, after being tested, may be useful for the elaboration
of health policies.
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